摘要
为了更早的诊断阿尔茨海默病(AD),检测神经病理敏感性与正常老化不敏感性有很大帮助。为了确定最适合区分轻度认知障碍(MCI)和早期AD与正常老龄化的方法,我们采用了多种神经病理学测试。长期记忆损害容易发生在老年人群,甚至MCI和AD患者的年龄更大。对分类流畅性测试,老年人比年轻人更适合作对照,并且产生了后天获得和不太熟悉的语言。老年人在这项任务中也比病人组做得好,产生了更多后天获得的、不太熟悉的及非典型的重要语言。长期记忆衰退的出现是不明确的,AD早期阶段的衰退不能帮助区分大脑正常的与病理上的衰老。正常衰老对语言流畅度没有副作用,对该信号损害不仅可以确定AD,而且可以确定它的MCI前驱阶段。
关键词: 认知年龄 ,阿尔茨海默病,情景记忆,轻度认知功能障碍,语言记忆,言语流畅
Current Alzheimer Research
Title:Differentiating Normal from Pathological Brain Ageing Using Standard Neuropsychological Tests
Volume: 11 Issue: 8
Author(s): Sarah J. Wakefield, William J. McGeown, Michael F. Shanks and Annalena Venneri
Affiliation:
关键词: 认知年龄 ,阿尔茨海默病,情景记忆,轻度认知功能障碍,语言记忆,言语流畅
摘要: To diagnose Alzheimer’s disease (AD) early, tests sensitive to neuropathology and insensitive to normal ageing are of greatest benefit. We used several neuropsychological tests to identify those best suited to distinguishing Mild Cognitive Impairment (MCI) and early AD from normal ageing. Impairments in long-term memory were found in older adults and these were even greater in MCI and AD. Older adults outperformed young controls on category fluency and produced later acquired and less familiar words. Older adults also outperformed both patient groups on this task producing more words which were significantly later acquired, less familiar and less typical. Decline in long-term memory appears nonspecific and in the early stage of AD cannot help the differentiation between normal and pathological brain ageing. Normal ageing has no negative effects on verbal fluency, and impairment on this task signals not only established AD, but also its prodromal MCI stage.
Export Options
About this article
Cite this article as:
Sarah J. Wakefield, William J. McGeown, Michael F. Shanks and Venneri Annalena, Differentiating Normal from Pathological Brain Ageing Using Standard Neuropsychological Tests, Current Alzheimer Research 2014; 11 (8) . https://dx.doi.org/10.2174/156720501108140910121631
DOI https://dx.doi.org/10.2174/156720501108140910121631 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Emerging Role of Regulatory T Cells in Gene Transfer
Current Gene Therapy HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities
Recent Patents on Nanotechnology Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Current Pharmaceutical Design Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation
Current Drug Safety Amphotericin B: From Derivatives to Covalent Targeted Conjugates
Mini-Reviews in Medicinal Chemistry Medical Applications of Implantable Drug Delivery Microdevices Based on MEMS (Micro-Electro-Mechanical-Systems)
Current Pharmaceutical Biotechnology Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Current Topics in Medicinal Chemistry Novel Pentapeptide Activators of Mammalian and Mushroom Tyrosinase
Current Topics in Medicinal Chemistry Methylation Profile of miR-9-1 and miR-9-1/-9-3 as Potential Biomarkers of Diabetic Retinopathy
Current Diabetes Reviews New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design CD164 as a Basophil Activation Marker
Current Pharmaceutical Design P2X7 Receptor as a Potential Target for Major Depressive Disorder
Current Drug Targets Advances in Stem Cell Therapy for Brain Diseases via the Intranasal Route
Current Pharmaceutical Biotechnology Adolescent Girls and their Mothers’ Knowledge and Opinions about Human Papilloma Virus Vaccine
Current Women`s Health Reviews Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Impact of Alzheimers Disease on the Functional Connectivity of Spontaneous Brain Activity
Current Alzheimer Research